| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.431.573 | 1.547.332 | - | 1.709.906 | 1.907.701 | 2.934.529 | 2.676.700 | 3.932.061 | 3.382.947 | 2.946.512 |
| Total Income - EUR | 1.488.252 | 1.530.632 | - | 1.738.311 | 2.062.584 | 2.939.212 | 2.730.297 | 3.988.570 | 3.434.402 | 6.085.213 |
| Total Expenses - EUR | 1.020.105 | 901.067 | - | 882.035 | 1.042.766 | 1.258.584 | 1.918.233 | 1.843.478 | 1.653.703 | 5.012.307 |
| Gross Profit/Loss - EUR | 468.146 | 629.565 | - | 856.276 | 1.019.818 | 1.680.627 | 812.064 | 2.145.092 | 1.780.699 | 1.072.906 |
| Net Profit/Loss - EUR | 366.269 | 535.259 | - | 716.556 | 847.623 | 1.414.710 | 678.679 | 1.785.506 | 1.547.036 | 872.785 |
| Employees | 27 | 30 | - | 27 | 29 | 31 | 52 | 47 | 22 | 27 |
Check the financial reports for the company - Amniocen Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 626.508 | 717.111 | - | 1.322.049 | 1.642.064 | 2.402.862 | 4.542.865 | 10.555.856 | 10.578.977 | 7.349.103 |
| Current Assets | 1.996.308 | 2.605.816 | - | 3.842.630 | 4.449.175 | 4.493.216 | 5.225.333 | 4.343.929 | 3.288.813 | 3.370.434 |
| Inventories | 115.053 | 84.644 | - | 100.927 | 82.941 | 154.454 | 205.064 | 257.165 | 168.747 | 133.825 |
| Receivables | 1.880.291 | 2.515.765 | - | 3.726.052 | 4.331.127 | 4.158.248 | 4.361.150 | 4.062.692 | 3.110.227 | 3.233.677 |
| Cash | 964 | 5.407 | - | 15.651 | 35.107 | 180.514 | 659.119 | 24.072 | 9.838 | 2.932 |
| Shareholders Funds | 1.994.234 | 2.509.154 | - | 3.879.928 | 4.652.411 | 5.841.519 | 5.911.743 | 6.068.976 | 7.242.671 | 8.104.371 |
| Social Capital | 45 | 45 | - | 43 | 42 | 41 | 42 | 43 | 42 | 201.076 |
| Debts | 499.156 | 689.641 | - | 1.181.112 | 1.334.519 | 955.052 | 3.763.903 | 8.736.441 | 6.549.200 | 2.527.618 |
| Income in Advance | 130.793 | 126.152 | - | 115.919 | 110.820 | 105.176 | 99.379 | 96.212 | 92.455 | 88.491 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2120 - 2120" | |||||||||
| CAEN Financial Year |
2120
|
|||||||||
Comments - Amniocen Srl